Pteridine derivatives, method of producing them and their application
1 Assignment
0 Petitions
Accused Products
Abstract
Compounds of the general formula (I) and their acid addition salts are provided
R1 signifies a piperazino, p-phenylenediamino, a 2,5-diazabicyclo-[2.2.1]-heptane, a 2,5-diazabicyclo-[2.2.2]-octane radical or a 3,8-diazabicyclo-[3.2.1]-octane radical, which in each case can be substituted with at least one substituent,
R2, R4, which are in each case the same, signify a pyrrolidino, thiazolidino, oxazolidino or imidazolidino radical, which in each case can be substituted with at least one substituent, and
R3 signifies an alkyl, alkoxy, alkylmercapto or an alkylamino radical, which in each case can be substituted with at least one substituent. These pteridine derivatives are suitable for the inhibition of phosphodiesterases and therefore for the prophylaxis and/or treatment of thrombo-embolic, neurodegenerative diseases, inflammatory diseases, asthmatic diseases as well as hemato-oncological diseases.
24 Citations
28 Claims
- 1. A compound of the general formula (I)
- 2. A compound of the general formula (I)
- 14. A compound of the general formula (II),
- 15. A compound of the general formula (II),
Specification